05.07.25 -- Looking For Support With Your Biologic API Or Drug Product?

We are your one integrated partner with the expertise to get your therapeutic product to market faster, helping you accelerate, simplify, and de-risk your biologics.

Curia offers comprehensive development and manufacturing services to meet needs through the entire lifecycle of your sterile drug product. Leverage our in-depth expertise and capabilities at any scale, from early clinical through large-scale commercial.

Unlock the potential of your antibody-drug conjugate development by partnering with our experts in bioconjugation to ensure the efficacy, safety, and scalability of your innovative therapies.

Our bestseller 132M HC is the perfect choice for challenging requirements. With its modular design, it is based on function groups. The system is highly flexible and offers a large number of individual options, a kind of off-the-shelf customization.

Leveraging robust analytical services at every stage of development and manufacturing is crucial to ensure your therapy reaches patients in need on time and within budget.

Discover how the Gore Protein A Membrane Device, in collaboration with AGC Biologics, can revolutionize your manufacturing processes, enhancing efficiency, scalability, and innovation from discovery to GMP-level production.

Partner with a global network of cGMP-certified mammalian cell culture manufacturing facilities to ensure scalable, high-quality biologics production and seamless global supply.

Ajinomoto Bio-Pharma Services offers a unique range of formulation and aseptic filling in vials, prefilled syringes, or cartridges to address production needs that span from small early stage clinical products to larger scale commercial products.

With decades of experience in drug delivery R&D, drug development, and manufacturing services, we’ve helped develop and commercialize multiple particle engineering based drug delivery platforms and supported many enhanced drug products.

Discover how advanced mRNA manufacturing innovations, including optimized RNA synthesis and scalable LNP encapsulation, are accelerating therapeutic development.

Using our proprietary GeneGPS^® and VectorGPS^® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bsAb in mammalian cells.

Early manufacturability assessments, complete cGMP solutions, and everything in between. FUJIFILM Diosynth Biotechnologies is a leading provider of cell culture services for biologics, advancing and delivering life-changing therapies.